Cytokintics looks great for a follow through on expansion breakout made a 2 month new high on surging volume due to being listed on the s&p smallcap 600 with last closing day being the largest in its range of the last 7-9 trading days. Buy stop in just above the breakout high with 1day expiry.
This stock is also undervalued, leading its peers with good fundamentals in recent headlines.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.